Scroll for more
events Nov 15, 2017

Pharma Integrates 2017

Join Patrick Keohane, CMO at BenevolentAI for a panel on Disruption from Afar: Embracing New Non-Pharma Technologies & Actors


Nov 15, 2017


09:00 AM


Grange City Hotel, London

Open in Google Maps >>


Is the future of pharma in the hands of drug manufacturing companies?

What role will technology companies such as Google, Apple, Amazon and potentially disruptive technology start-ups play in healthcare? They bring capabilities such as advanced analytics, artificial intelligence, cloud technology and software development that are increasingly appealing to incumbent pharma companies who want to expand their value proposition and play a broader role in healthcare. They have a different view on innovation and return on investment i.e., moving from developing and commercialising medicines to delivering better outcomes by adding patient-centric and technology-enabled services and solutions.


Steve Arlington President, Pistoia Alliance


Andrew Thompson President & Chief Executive Officer, Proteus Digital Health
Patrick Keohane Chief Medical Officer, BenevolentAI
Ray Barlow Chief Executive Officer, e-Therapeutics
Professor Sue Hill OBE Chief Scientific Officer NHS England